FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure
The first-in-human clinical trial for a candidate treatment for individuals living with human immunodeficiency virus type 1 is starting soon after its maker, Excision BioTherapeutics, today received an Investigational New Drug clearance from the U.S. Food and Drug Administration (FDA).
No comments:
Post a Comment